Syngene International Limited

Healthcare · Healthcare Services

NSE: SYNGENE BSE: 539268

About Syngene International Limited

No company profile on record yet.

Key facts

BSE symbol539268
NSE symbolSYNGENE
ISININE398R01022
CINL85110KA1993PLC014937
Listing date11 Aug 2015
Fiscal year end31 Mar
SectorHealthcare
IndustryHealthcare Services
AuditorV. Sreedharan & Associates, Company Secretaries (V Sreedharan)
Registered officeBiocon SEZ, Biocon Park, Plot No 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bommasandra Bengaluru 560 099
Registrar & transfer agentKFin Technologies Limited Selenium Tower B, Plot No-31 & 32, Financial District, Nanakramguda, Serilingampally, Rangareddi, Hyderabad-500032
Index memberships

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)3,491†3,444†3,291†3,264†2,654†
Net profit305468466473394†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
KIRAN MAZUMDAR SHAWExecutive DirectorJune 30, 2026
PETER JAMES JONATHAN BAINSExecutive DirectorJune 30, 2026
KUSH PARMARIndependent DirectorJune 30, 2026
MANJA BOERMANIndependent DirectorJune 30, 2026
NILANJAN ROYIndependent DirectorJune 30, 2026
SANJAYA SINGHIndependent DirectorJune 30, 2026
SHARMILA ABHAY KARVEIndependent DirectorJune 30, 2026
SURESH NARAYANANIndependent DirectorJune 30, 2026
CATHERINE PATRICIA ROSENBERGNon-Executive DirectorJune 30, 2026
VINITA BALINon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.